The state of Missouri currently has 1 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. These trials are conducted in various cities, including Saint Louis, Kansas City, St. Louis and Springfield.
IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
Recruiting
To Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
02/18/2025
Locations: Kansas City Research Institute, Kansas City, Missouri
Conditions: Primary Biliary Cholangitis